The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...
The judge overseeing the University of Idaho case denied suspect Bryan Kohberger's request to exclude potentially key DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback